chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received foe the Pregnancy Registry from an 18 year old female with penicillin allergy and sulfonamide allergy and a history of tonsillectomy who in January 2007, was vaccinated with the first dose of Gardasil. There was no concomitant medication. The same day of vaccination, the patient felt dizzy and tired. These events only lasted for one day and the patient recovered. Subsequently the patient learned that she is pregnant. The exact date of conception is not known; however, she believes it was right around the time of vaccination (LMP 10-JAN-2007, EDD 17-OCT-2007). With regard to her pregnancy, she has not had any adverse symptoms. Therapy was stopped when she learned she was pregnant. Unspecified medical attention was sought. Additional information has been requested.
Patient had hypertension and Lightheadedness approx 5 min post COVID vaccine, improved after resting.  Pt transported to ED via EMS for follow-up. Administered famotidine 20mg iv in the ED.
In November 2022, I had bladder pressure, which prompted me to call my doctor's office and be seen. By the end of December 2022, I underwent an ultrasound that detected a mass. On 1/4/2023, I underwent surgery to have the mass removed. It was then discovered that I had stage 3 ovarian cancer. I started chemotherapy on 1/31/2023. Since then, I have been receiving chemotherapy treatments every three weeks. I have had three treatments so far, and I'm due to receive three more in the future, with the last one being in May 2023. I underwent a CT scan at some point in mid-January 2023, and the cancer was elevated from stage 3 to stage 4, because cancerous lesions were discovered on my bowels and my left lung. This did not change in any way the planned course of treatment, but during the 1/4/2023 surgery, I had 11 cm of my lower intestine removed before I could start chemotherapy. I am temporarily using a colostomy in the meantime. I will have to wait until at least a month after the final chemotherapy treatment to see about having it reversed.
Started with elbow joint pain then progressed to all joint pain. Visited Drs who referred her to Rheumatologist who diagnosed Palindromic Rheumatism. Is on Pain killers daily and Hydrochloroquinnine.
Information has been received from a nurse concerning a pt who on 22AUG2003 was vaccinated IM with a dose of pneumococcal vaccine 23 polyvalent. On 22AUG2003 the pt developed a fever of 102F, and itching and redness at the site of the injection. Unspecified medical attention was sought and it was unknown if a prescription drug was required. No product quality complaint was involved. It was also reported that another pt was vaccinated wit a dose of pneumococcal vaccine 23 polyvalent and developed itching and redness at the injection site. Additional information has been requested.
Information regarding PREVNAR 7 was received fro ma healthcare professional regarding a patient who experienced rash. The patient received a dose on an unspecified date. Relevant medical history was not provided. Indication for PREVNAR. Product was administered on an unspecified date. Dose regimen was 1 dose 1 time per day (intramuscular). Concomitant medications were not reported. On an unspecified date, the patient experienced rash. The outcome was unknown. See related case (s): US WYE H15128310 (adverse event, non expedited) and US WYE H15204510 (adverse event, non expedited). No additional information was available at the time of this report.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 28-JUL-2017 the patient was vaccinated with GARDASIL 9 dose 3 for prophylaxis. On 28-JUL-2017, 6 months 9 days after onset of therapy the patient experienced inappropriate schedule of drug administration. On an unknown date the patient experienced no adverse event. The outcome of inappropriate schedule of drug administration and no adverse event is unknown. The reporter considered inappropriate schedule of drug administration and no adverse event to be not related to GARDASIL 9.
Patient upon seated for the 15 minutes post-vaccination fainted. When she was coming through, she started shaking as if she was having a seizure. When I reached the patient, she was shaking and then came through and stopped shaking. Patient was still pale, sweating, and didn't feel okay. 911 was already called once the patient was shaking. As I am checking in on the patient, the mom discloses that she has fainted at least twice before and when she comes through she shakes but it is not seizures. However, during the screening process, patient and mom stated the patient never had any problems when getting vaccinated. I got her BP checked and it was 102/61 and HR of 92. We had the patient sit still and drink water. When EMS arrived within 5-10 mins, they took her vitals and it was 112/70s and HR of 84 with 98% O2 sat. Patient and mom decided to be taken to the ED to make sure she is okay.
frozen shoulder; can't lift my arm all the way up; very restricted in motion; very sore shoulder where she had the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PERIARTHRITIS (frozen shoulder), HYPOKINESIA (can't lift my arm all the way up), MOBILITY DECREASED (very restricted in motion) and VACCINATION SITE PAIN (very sore shoulder where she had the vaccine) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 039K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIARTHRITIS (frozen shoulder), HYPOKINESIA (can't lift my arm all the way up), MOBILITY DECREASED (very restricted in motion) and VACCINATION SITE PAIN (very sore shoulder where she had the vaccine). The patient was treated with Physical therapy for Vaccination site pain. At the time of the report, PERIARTHRITIS (frozen shoulder), HYPOKINESIA (can't lift my arm all the way up), MOBILITY DECREASED (very restricted in motion) and VACCINATION SITE PAIN (very sore shoulder where she had the vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included unspecified cholesterol medication  Treatment included physical therapy for pain and inflammation.; Sender's Comments: This case concerns a 49-year-old female patient with no relevant medical history, who experienced the unexpected non-serious events of periarthritis, hypokinesia and mobility decreased and the expected non-serious event of vaccination site pain. The events occurred on unknown days after the second dose of mRNA- 1273 vaccine / Moderna COVID-19 Vaccine. The rechallenge was not applicable, as the events were reported after the second dose and no additional dosing will be given. The benefit-risk relationship of  vaccine is not affected by this report
large red area on the arm; area was bumpy like a rash; A spontaneous report was received from a Consumer concerning a 83-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events large red area on the arm(erythema), area was bumpy like a rash(rash).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 2 Feb 2021,approximately 4 days prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 038K20A) intramuscularly in arm for prophylaxis of COVID-19 infection.  On 5 Feb 2021, the patient experienced the event(s) large red area on the arm and area was bumpy like a rash.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s) large red area on the arm and area was bumpy like a rash was considered resolved on 15 Feb 2021. .
Developed maculopapular rash, blistered and scabbing few lesions only.
Patient was given her 6 month set of vaccines during her office visit on 8/11/15. Patient's mother called later that afternoon worried that patient was vomiting and lethargic. Patient was taken to her local ER and was told this was a reaction to the Rotavirus vaccine. She was given ZOFRAN and fluids. Today patient has returned to normal according to her mother.
Fever, stiff neck, pain in low back, full body aches, flushed face.
Hives appeared ~ 15 min after vaccine administration. Had emesis after oral BENADRYL given. so IM BENADRYL given with resolution of symptoms within 20-30 minutes. Pt observed for ~2hrs-did well.
according to pt mom child awoke 2AM c/o abd pain;mom accompanied child to bathoom-child voided p/void child had LOC, eyes rolled up & gen tonic-clonic move sym of extremities lasting few min w/o urin/stool incont;taken to hosp;
Myalgias; Fever 101.2; Headache; Vomiting; Nausea; Diarrhea; Abdominal cramping; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), ABDOMINAL PAIN (Abdominal cramping), MYALGIA (Myalgias), PYREXIA (Fever 101.2) and HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), ABDOMINAL PAIN (Abdominal cramping), PYREXIA (Fever 101.2), HEADACHE (Headache), VOMITING (Vomiting) and NAUSEA (Nausea). an unknown date, the patient experienced MYALGIA (Myalgias). At the time of the report, DIARRHOEA (Diarrhea), ABDOMINAL PAIN (Abdominal cramping), MYALGIA (Myalgias), PYREXIA (Fever 101.2), HEADACHE (Headache), VOMITING (Vomiting) and NAUSEA (Nausea) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 101.2 101.2.         Concomitant product used not provided by the reporter.  The patient reported they had a pretty intense reaction to the second vaccine. They had diarrhea for about two weeks. They had to take two days off from work.   Treatment information was not provided.
Pediarix intead of Dtap 4th dose; This case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 15-month-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number x9hs4, expiry date 25th March 2024) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Dtap vaccine (received 1st dose 19th October 2021), Dtap vaccine (received 2nd dose on 23rd December 2021) and Dtap vaccine (received 3rd dose 24th February 2022).   On 28th November 2022, the patient received Pediarix and Pediarix Pre-Filled Syringe Device. On 28th November 2022, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 01-DEC-2022 Reporter's comment: The reporter reported that 15 months old patient supposed to be receiving a Dtap 4th dose but Pediarix was administered instead.  The patent previously received 3 doses of Dtap vaccine. The vaccine administration facility was the same as primary reporter. The reporter did not consent to follow-up. Additional supportive information: The patient received Pediarix vaccine instead of Dtap vaccine, which led to Wrong vaccine administered.
Severe Headache, body ache, loss of appetite and thirst, slight vomiting, extremely tired, chills and sweats.
I had a little nausea and dizziness after the first dose of the vaccine for a few days after. After I got the second dose of the vaccine I had a fever and major headaches for several days as well as nausea and stomach cramps. I had some dizziness and nausea within the first 45 minutes. When I got home my head was pounding and I was coughing a lot. I went to Urgent Care four days after the shot and my tests were negative. It has been over a month but I am still getting headaches and dizziness. It seems like my Fibromyalgia and Chronic Fatigue are flared up. I have been having some shaking and weakness in my hands. I have had some problems with this in the past but it has gotten much worse. The coughing has improved and only happens occasionally. I have been having some problems with memory recently too.
On March 11 soreness in arm and on the 12th feeling feverish. My chest started hurting for about two weeks then came back. Body aches and joint aches bothered me for a few weeks then gone. All done two weeks later after 2nd shot fine.
Mom called in to office and said patient's arm was red at site of injection. Mom sent a picture to Dr.'s phone. Redness appeared to be 3x3 inch circle of redness on right deltoid area.
mom brought pt to clinic & pt broke out in rash w/in 1hr p/vax;no SOB or swelling;erythematous confluent macular rash visualized areas of excoriation on neck & back;pt c/o itching on upper thighs & cheeks;given DPH;
Received Janssen vaccine on 4/8/21 COVID-19 positive by PCR on  1/4/22 admitted to hospital on 1/6/22 d/t meth intoxication, minimally symptomatic for COVID
the fever was strong the night he received the vaccine; This is a spontaneous report from a contactable consumer or other non hcp. A 28-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 19Apr2021 as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced the fever was strong the night he received the vaccine on 19Apr2021 and has been less severe since then with a range of 37.8-38°C. Outcome of the event was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
I started on Sunday evening experiencing rapid heart beat had trouble catching my breath lasted to Tuesday afternoon. I called my sister in law she is NP advised me to call my doctor. My doctor informed me that was common side effects to continue to monitor if symptoms worsened to go to the hospital.
Low grade fever; body ache; headache; stomachache; tiredness; This is a spontaneous report from a contactable consumer (patient himself).  A 51-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number:  not reported; Expiry date: not reported), via an unspecified route, administered in Arm Left on 17Apr2021 at 13:00 (Age at vaccination 51-years-old) as dose number unknown, single for covid-19 immunization. Medical history included hepatitis C, when a child and toothache. The patient had no known allergies. Concomitant medications included ibuprofen (ADVIL [IBUPROFEN]) taken for toothache. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Apr2021 at 21:00, the patient experienced low grade fever, body ache, headache, stomach ache and tiredness. Therapeutic measures were taken for events and patient received 400 mg advil on sunday night as treatment for the events. The clinical outcome of the events was recovering.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
I took 2nd Covid shot yesterday and I'm kind of tired; This is a spontaneous report received from a Pfizer-sponsored program. A contactable 69-year-old female consumer (patient) reported for herself that she received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 06Jun2021 as single dose for covid-19 immunisation. The patient medical history were not reported. The patient's concomitant medication included Xeljanz 5 mg (tofacitinib citrate). The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient reported that she took 2nd covid shot yesterday and she was kind of tired. The outcome of the event was unknown.    Information about the Lot/batch number has been requested.
Symptoms: vertical diplopia followed by oscillopsia with nystagmus Time Course: Appeared suddently the afternoon of April 1st and continued for one week. After one week, the symptoms gradually improved. At 4 weeks, only about 5% of the symptoms remain (oscillopsia in the morning, trouble with reading small text, trouble with vision to the right) Treatment: No treatment.
This spontaneous report as received from a consumer refers to herself: a 60 year old female. The patient's concurrent condition included: hyperthyroid, high blood pressure, high ITF 2, osteoporosis, high immunoglobulin E (IGE), unspecified allergies (also reported as the patient did not have drugs reactions and allergies). On 05-FEB-2016, the patient was vaccinated with ZOSTAVAX 0.65 ml single shot subcutaneous (site of administration lot number and expiration date were not reported). Concomitant therapies included methimazole (manufacturer unknown), propranolol hydrochloride (manufacturer unknown), diazepam (manufacturer unknown) and zolpidem. On 06-FEB-2016, she noticed injection site redness, swelling and pain. She sought medical attention at unspecified Urgent Care facility. She was diagnosed with cellulitis and prescribed KEFLEX. She has taken six doses of the antibiotics since 06-FEB-2016 and her reactions have not improved. The patient stated that at the time of the report, the injection site has redness, swelling, itching, pain, hard to the touch and is warm to the touch. The outcome of the events was reported as not recovered/not resolved. The relatedness between adverse events and ZOSTAVAX was not reported. Additional information is not expected as the patient did not wish to be contacted.
painful/pain in left underarm; reactive lymph node; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (painful/pain in left underarm) and VACCINATION SITE LYMPHADENOPATHY (reactive lymph node) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced VACCINATION SITE PAIN (painful/pain in left underarm) and VACCINATION SITE LYMPHADENOPATHY (reactive lymph node). At the time of the report, VACCINATION SITE PAIN (painful/pain in left underarm) and VACCINATION SITE LYMPHADENOPATHY (reactive lymph node) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: no results provided no results provided.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medication were reported.  The patient received the second vaccination on 09-Apr-2021 with Lot number as 030B21A, expiration dates as 20Sep2021 and received the injection on right arm.   After receiving the first dose of the Moderna vaccine, patient had pain in left underarm and a reactive lymph node. This has continued for the past year.  Patient had seen 2 doctors who performed a sonogram, but did not offer any treatment options as surgery would have the possibility of nerve damage.  Patient has not tried any medications or treatments to help with the symptoms.
15 minutes post vax, the pt developed 4 tiny hives on feet. Hives were about 3 mm in diameter. No other symptoms.
pt recv vax 20MAY96 & 22MAY96 pt exp swelling & erythema @ inj site, 6cm x 8cm full thickness & a sore leg;pt seen by MD on 22MAY96 & application of ice to the site was recommended;
Patient came to pharmacy to report adverse reaction he believes he got from Covid Booster. Patient reported left shoulder paralysis that went from shoulder that shot down to left leg.  I asked if he could at all move his arms or legs at that time, he said he can move however it caused a lot of pain/cramps. Started on 9/26 when he got the shot and resolved and got better today on 10/4 when he came to pharmacy to pick up his prescription. Because it was on left side, also instructed patient to let his cardiologist know about the adverse effects.
A non-serious spontaneous report of inadvertent administration to 57 year old was received from a registered nurse concerning a 57-year-old female. The relevant medical history was not reported for this patient. On 30-Dec-2009, the patient received H1N1, Intranasal. There was no adverse event associated with this medication error; therefore, treatment and reporter's causality assessments are not applicable and the event was considered resolved.
Redness and itchy on the whole arm below the injected area. Pain in under armpit like lymph node swollen
She got the vaccine, had no reactions. On 3/6/21 she had blurred vision and being a little confused.  On the 8th when he returned back from work and she took her blood sugar which was 579.  So he rushed her immediately to urgent Care, they checked her blood sugar and there was no reading, and they sent her to Hospital.  In the ER at the hospital it was 408.  They gave her insulin, stabilized her and they told her to check with her doctor.  She consulted with her physician the next day and they put her on Metformin, which did not bring the blood sugar down at all.  On 3/10/21 he took her back to the ER again and they stabilized her again and did more testing to rule out any stroke or anything else, but also informed her that the vaccine pushed her over the pre-diabetic stage to being a diabetic.   She went back to the doctor again who increased her Metformin on 3/16/21, and her levels are still not within acceptable range but better than 300-400, but are in the 200+ ranges.   She is very dizzy, weak for the last 3 weeks and her vision is blurry as well, and she is not able to work as a nurse due to these reactions.   She does have a doctors note that she can return to work tomorrow without restrictions.  Her blood pressure was extremely high as well, and her physician increased her medicine.